Molecular Pharmaceutics, volume 18, issue 1, pages 461-468

New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma

Mefedova Sofiia R 2
Lopatukhina Elena V. 2
Timchenko Yury V 2
Ondar Evgenia E 2
Ivanenkov Yan 1, 5
Evteev Sergei A 2
Timoshenko Roman V 3
Gorelkin Peter 2, 3
Publication typeJournal Article
Publication date2020-12-02
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.9
ISSN15438384, 15438392
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract
In this work, we have developed covalent and low molecular weight docetaxel delivery systems based on conjugation with N-acetyl-d-galactosamine and studied their properties related to hepatocellular carcinoma cells. The resulting glycoconjugates have an excellent affinity to the asialoglycoprotein receptor (ASGPR) in the nanomolar range of concentrations and a high cytotoxicity level comparable to docetaxel. Likewise, we observed the 21-75-fold increase in water solubility in comparison with parent docetaxel and prodrug lability to intracellular conditions with half-life values from 25.5 to 42 h. We also found that the trivalent conjugate possessed selective toxicity against hepatoma cells vs control cell lines (20-35 times). The absence of such selectivity in the case of monovalent conjugates indicates the effect of ligand valency. Specific ASGPR-mediated cellular uptake of conjugates was proved in vitro using fluorescent-labeled analogues. In addition, we showed an enhanced generation of reactive oxygen species in the HepG2 cells, which could be inhibited by the natural ligand of ASGPR. Overall, the obtained results highlight the potential of ASGPR-directed cytostatic taxane drugs for selective therapy of hepatocellular carcinoma.

Citations by journals

1
2
Russian Journal of Organic Chemistry
Russian Journal of Organic Chemistry, 2, 9.52%
Russian Journal of Organic Chemistry
2 publications, 9.52%
Inorganic Chemistry Frontiers
Inorganic Chemistry Frontiers, 1, 4.76%
Inorganic Chemistry Frontiers
1 publication, 4.76%
RSC Medicinal Chemistry
RSC Medicinal Chemistry, 1, 4.76%
RSC Medicinal Chemistry
1 publication, 4.76%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 4.76%
Journal of Nanobiotechnology
1 publication, 4.76%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 4.76%
International Journal of Molecular Sciences
1 publication, 4.76%
Journal of Cluster Science
Journal of Cluster Science, 1, 4.76%
Journal of Cluster Science
1 publication, 4.76%
Molecular Pharmaceutics
Molecular Pharmaceutics, 1, 4.76%
Molecular Pharmaceutics
1 publication, 4.76%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 4.76%
Journal of Medicinal Chemistry
1 publication, 4.76%
European Journal of Organic Chemistry
European Journal of Organic Chemistry, 1, 4.76%
European Journal of Organic Chemistry
1 publication, 4.76%
Advanced healthcare materials
Advanced healthcare materials, 1, 4.76%
Advanced healthcare materials
1 publication, 4.76%
Molecules
Molecules, 1, 4.76%
Molecules
1 publication, 4.76%
International Journal of Nanomedicine
International Journal of Nanomedicine, 1, 4.76%
International Journal of Nanomedicine
1 publication, 4.76%
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids, 1, 4.76%
Molecular Therapy - Nucleic Acids
1 publication, 4.76%
SSRN Electronic Journal
SSRN Electronic Journal, 1, 4.76%
SSRN Electronic Journal
1 publication, 4.76%
Cells
Cells, 1, 4.76%
Cells
1 publication, 4.76%
Moscow University Chemistry Bulletin
Moscow University Chemistry Bulletin, 1, 4.76%
Moscow University Chemistry Bulletin
1 publication, 4.76%
Lomonosov chemistry journal
Lomonosov chemistry journal, 1, 4.76%
Lomonosov chemistry journal
1 publication, 4.76%
Colloid Journal
Colloid Journal, 1, 4.76%
Colloid Journal
1 publication, 4.76%
Analytical Chemistry
Analytical Chemistry, 1, 4.76%
Analytical Chemistry
1 publication, 4.76%
Science China Life Sciences
Science China Life Sciences, 1, 4.76%
Science China Life Sciences
1 publication, 4.76%
1
2

Citations by publishers

1
2
3
4
Pleiades Publishing
Pleiades Publishing, 4, 19.05%
Pleiades Publishing
4 publications, 19.05%
Springer Nature
Springer Nature, 3, 14.29%
Springer Nature
3 publications, 14.29%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 14.29%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 14.29%
American Chemical Society (ACS)
American Chemical Society (ACS), 3, 14.29%
American Chemical Society (ACS)
3 publications, 14.29%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 9.52%
Royal Society of Chemistry (RSC)
2 publications, 9.52%
Wiley
Wiley, 2, 9.52%
Wiley
2 publications, 9.52%
Dove Medical Press
Dove Medical Press, 1, 4.76%
Dove Medical Press
1 publication, 4.76%
Elsevier
Elsevier, 1, 4.76%
Elsevier
1 publication, 4.76%
Social Science Electronic Publishing
Social Science Electronic Publishing, 1, 4.76%
Social Science Electronic Publishing
1 publication, 4.76%
Moscow University Press
Moscow University Press, 1, 4.76%
Moscow University Press
1 publication, 4.76%
1
2
3
4
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Petrov R. A. et al. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma // Molecular Pharmaceutics. 2020. Vol. 18. No. 1. pp. 461-468.
GOST all authors (up to 50) Copy
Petrov R. A., Mefedova S. R., Yamansarov E. Yu., Maklakova S., Grishin D. A., Lopatukhina E. V., Burenina O. Y., Lopukhov A. V., Kovalev S., Timchenko Y. V., Ondar E. E., Ivanenkov Y., Evteev S. A., Vaneev A. N., Timoshenko R. V., Klyachko N. L., Erofeev A. V., Gorelkin P., Beloglazkina E. K., Majouga A. G. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma // Molecular Pharmaceutics. 2020. Vol. 18. No. 1. pp. 461-468.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.molpharmaceut.0c00980
UR - https://doi.org/10.1021%2Facs.molpharmaceut.0c00980
TI - New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma
T2 - Molecular Pharmaceutics
AU - Mefedova, Sofiia R
AU - Grishin, Dmitrii A
AU - Lopatukhina, Elena V.
AU - Ondar, Evgenia E
AU - Timoshenko, Roman V
AU - Evteev, Sergei A
AU - Petrov, Rostislav A
AU - Yamansarov, Emil Yu
AU - Maklakova, Svetlana
AU - Lopukhov, Anton V
AU - Kovalev, Sergey
AU - Ivanenkov, Yan
AU - Vaneev, Alexander N.
AU - Klyachko, Natalia L.
AU - Majouga, Alexander G.
AU - Burenina, Olga Y
AU - Timchenko, Yury V
AU - Erofeev, Alexander V.
AU - Gorelkin, Peter
AU - Beloglazkina, Elena K.
PY - 2020
DA - 2020/12/02 00:00:00
PB - American Chemical Society (ACS)
SP - 461-468
IS - 1
VL - 18
SN - 1543-8384
SN - 1543-8392
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Petrov,
author = {Sofiia R Mefedova and Dmitrii A Grishin and Elena V. Lopatukhina and Evgenia E Ondar and Roman V Timoshenko and Sergei A Evteev and Rostislav A Petrov and Emil Yu Yamansarov and Svetlana Maklakova and Anton V Lopukhov and Sergey Kovalev and Yan Ivanenkov and Alexander N. Vaneev and Natalia L. Klyachko and Alexander G. Majouga and Olga Y Burenina and Yury V Timchenko and Alexander V. Erofeev and Peter Gorelkin and Elena K. Beloglazkina},
title = {New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma},
journal = {Molecular Pharmaceutics},
year = {2020},
volume = {18},
publisher = {American Chemical Society (ACS)},
month = {dec},
url = {https://doi.org/10.1021%2Facs.molpharmaceut.0c00980},
number = {1},
pages = {461--468},
doi = {10.1021/acs.molpharmaceut.0c00980}
}
MLA
Cite this
MLA Copy
Petrov, Rostislav A., et al. ā€œNew Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.ā€ Molecular Pharmaceutics, vol. 18, no. 1, Dec. 2020, pp. 461-468. https://doi.org/10.1021%2Facs.molpharmaceut.0c00980.
Found error?